Current Issue : January-March Volume : 2022 Issue Number : 1 Articles : 5 Articles
Introduction: Pain control during Manual Vacuum Aspiration is one of the most important aspects of postabortion care. This study assessed the analgesic efficacy, requirement for additional analgesia, and overall satisfaction using Paracervical blocks of 1% lignocaine compare with normal saline as placebo among women undergoing manual vacuum aspiration for incomplete abortion in OAUTHC, Ile-Ife. Methods: This was a double blind randomized controlled trial that occurred between January 2019 and February 2020. We randomized one hundred and twenty eligible women equally into 2 groups. Group A received paracervical block using 1% lignocaine while those in group B received paracervical block using normal saline as placebo. We obtained ethical clearance from the Ethics and Research Committee of the hospital. Preoperatively, we obtained relevant data and evaluated the degree of anxiety and pain on a visual analog scale (VAS). Intraoperative pain was evaluated from 2 viewpoints: that of the external observer on a 0 - 4 scale and that of the patient scale of 0 - 10 in the immediate postoperative period, followed by overall satisfaction at the point of discharge. We analyzed the data using SPSS version 20. Paired T test, independent T test Chi square, and Fishers’ exact tests were applied for continuous and categorical variables as appropriate. P value < 0.05 was considered as statistically significant. Results: The Intra-operative and Postoperative VAS was significantly higher in the placebo group compared to the analgesia group (t = −3.39, CI −4.11 - −2.69. P < 0.05 intra-operative, t = 7.18, CI 2.62 - 4.61. P < 0.05 post-operative). The need for additional analgesia and mean VAS of those in the placebo group was significantly higher than that of the study group with higher overall satisfaction rate in the study group (t = 7.18. CI 2.62 - 6.71. P < 0.0001). Conclusions: Paracervical block with 1% lignocaine is more effective in reducing pain during manual vacuum aspiration compared to placebo. It has added advantage of a higher overall satisfaction rate and reduced need for additional analgesia....
Eclampsia is one of the most sever, life-threatening diseases occurred in pregnancy, MgSO4 is the best drug used for its treatment. In this study, the comparison between shortened regimen of MgSO4 versus standard Zuspan course in controlling eclampsia was done. This study performed along one year (July 2019-July 2020) at El Shatby Maternity University Hospital, 40 eclamptic patients presenting at the emergency unit were randomized. Group A received the standard Zuspan regimen of magnesium sulphate and group B received short course in which the patients received only two doses of intravenous magnesium sulphate four hours apart postpartal. Results: The maternal outcomes regarding recurrence of the fits were compared. The maternal complications and postpartal fits were the same in both groups. The dose of MgSO4 in the shortened group was decreased by 40% in 42.5% of the cases. Conclusions: The shortened course of MgSO4 postpartal is the same as the standard regimen in the controlling eclampsia....
Background: Molar pregnancy is a rare condition; its ectopic form is even rarer occurring in 1.5 per 1,000,000 pregnancies. Aim: We report a case of ectopic molar pregnancy located in the fallopian tube and draw attention to the importance of systematic histological examination in any ectopic pregnancy. Case report: A 32-year-old primigravida woman presented with metrorrhagia in a context of about 2 months of amenorrhea. An ectopic pregnancy was diagnosed by ultrasonography. A Laparotomy was performed and a ruptured left ampullary ectopic pregnancy was found, and a total left salpingectomy was performed. The pathologic examination and the histological examination show an aspect of a partial molar ectopic tubal pregnancy. Conclusion: Ectopic molar pregnancy is a rare entity, its diagnosis requires histological confirmation. Beta-HCG monitoring is the essential tool for monitoring the postoperative evolution....
Introduction: Maternal mortality is a robust indicator of human development. Most of it occurs in developing countries. Objectives: This study aims to determine the factors associated with maternal mortality in Gynecology and Obstetrics Department of Borgou Departmental University Hospital Center (CHUD-B). Study method: Our study took place at Gynecology and Obstetrics Department in Borgou Departmental University Hospital Center. This was a descriptive and analytical case-control study, covering a period of 7 years from January 1, 2012 to December 31, 2018. Results: Two hundred and twelve patients have been recruited consisting of 106 deceased women and 106 controls. The intra-hospital mortality ratio was 1100 deaths per 100,000 live births (LB). The mean age of deceased women was 27.06 ± 6.45 years with the extremes of 15 and 45 years. Direct obstetric causes were the most frequent causes of maternal death. They were dominated by immediate postpartum hemorrhage (32.93%), followed by High Blood Pressure (26.83%) and infections (17.07%). The general condition of patients on admission (p-0.000) and inadequate management (p-0.001) was associated with maternal mortality. Conclusion: Patients’ general condition on admission and inadequate management was factors associated with maternal mortality....
Objective: To evaluate the results of ART (clinical pregnancies and baby home rates) in couples infected with HBV, HCV, HIV or mixed in a Referral center. Patients: The study is a retrospective case-control study comprising 1587 cycles/1064 couples in the control group and 237 cycles/164 couples in the infected group, submitted to in vitro fertilization, intracytoplasmic sperm injection and embryo transfer. Two branches from the infected group were created: the HIV subgroup, comprising couples with one or both partners infected with HIV-1 (84 cycles/67 couples), and the HCV subgroup, including at least one partner infected with HCV (45 cycles/29 couples). Results: The infected group presented higher infertility duration (P < 0.001) and so did the HCV subgroup (P < 0.001). Tubal infertility was increased in the infected group (P < 0.001), and in the HIV (P < 0.001) and HCV (P = 0.01) subgroups. Oocytes and oocytes in metaphase II numbers were lower in the infected group, but not in the HIV and HCV subgroups. Clinical pregnancy rate was lower in the infected group (25.74%) when compared to the control (34.66%), probably due to the contribution of HCV individuals (17.78%), but not of HIV (28.57%). Baby home rate was lower in the infected group (21.52%) relative to the control group (28.42%), but no differences were found in the HIV (27.38%) and HCV (15.56%) subgroups. Conclusions: Despite the low clinical pregnancy rate in the HCV subgroup, baby home rates did not change from control. These data seem promising for couples with viral infections who wish to conceive....
Loading....